[1]王清华.家庭参与式护理干预对精神分裂症患者生活质量的影响[J].医学信息,2022,35(02):187-189.[doi:10.3969/j.issn.1006-1959.2022.02.050]
　WANG Qing-hua.Effect of Family Participatory Nursing Intervention on Quality of Life in Patients with Schizophrenia[J].Medical Information,2022,35(02):187-189.[doi:10.3969/j.issn.1006-1959.2022.02.050]
点击复制

家庭参与式护理干预对精神分裂症患者生活质量的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年02期
页码:
187-189
栏目:
护理研究
出版日期:
2022-01-15

文章信息/Info

Title:
Effect of Family Participatory Nursing Intervention on Quality of Life in Patients with Schizophrenia
文章编号:
1006-1959（2022）02-0187-03
作者:
王清华
普兰店区南山医院康复科，辽宁 大连 116200
Author(s):
WANG Qing-hua
Department of Rehabilitation,Nanshan Hospital of Pulandian District,Dalian 116200,Liaoning,China
关键词:
精神分裂症; 家庭参与护理; 生活质量; 服药依从性
Keywords:
Schizophrenia; Family participatory nursing; Quality of life; Medication compliance
分类号:
R473
DOI:
10.3969/j.issn.1006-1959.2022.02.050
文献标志码:
A
摘要:
目的 研究家庭参与式护理干预对精神分裂症患者生活质量的影响。方法 选取2019年3月-2020年3月我院康复科收治的98例精神分裂症患者，按照随机数字表法分为对照组与观察组，每组49例。对照组采用常规护理干预，观察组在对照组基础上采用家庭参与式护理干预，比较两组服药依从性、简明精神病评定量表（BPRS）、住院精神病人康复疗效评价量表（IPROS）、焦虑评定量表（SAS）、抑郁评定量表（SDS）、精神分裂症患者生活质量量表（SQLS）评分。结果 观察组服药依从优良率高于对照组，差异有统计学意义（P＜0.05）。两组干预后BPRS、IPROS、SAS、SDS及SQLS各量表评分低于干预前，且观察组低于对照组，差异有统计学意义（P＜0.05）。结论 家庭参与式护理干预可提升患者服药依从性，改善康复效果，缓解负面情绪，提高生活质量。
Abstract:
Objective To study the impact of family participatory nursing intervention on the quality of life of patients with schizophrenia.Methods A total of 98 patients with schizophrenia admitted to our hospital from March 2019 to March 2020, which were divided into the control group and the observation group according to a random number table, with 49 cases in each. The control group received routine nursing intervention, and the observation group received family participatory nursing intervention on the basis of the control group. The medication compliance, the Brief Psychiatric Rating Scale (BPRS), the Inpatient Psychiatric Patient Rehabilitation Evaluation Scale (IPROS), Anxiety Rating Scale (SAS), Depression Rating Scale (SDS), and Schizophrenia Quality of Life Scale (SQLS) scores were compared between the two groups.Results The rate of good compliance with medication in the observation group was higher than that in the control group, the difference was statistically significant (P＜0.05). The scores of BPRS, IPROS, SAS, SDS and SQLS in the two groups after intervention were lower than those before intervention, and those in the observation group were lower than those in the control group, the difference was statistically significant (P<0.05).Conclusion Family participatory nursing intervention can improve patient compliance with medication, improve rehabilitation efficacy, and further improve negative emotions and quality of life.

参考文献/References:

[1]张红梅,赵占胜,孙志刚,等.精神分裂症患者家庭社会支持情况对自我效能感及预后的影响[J].国际精神病学杂志,2017,44(1):9-11,19.[2]陈玉婵,陈锦燕.家庭护理对精神分裂症患者康复与护理满意度的影响[J].中国医药科学,2019,9(24):164-166.[3]牛艳.支持性护理联合家属参与护理对精神分裂症患者依从性、社会功能及照顾者心理状态的影响[J].国际护理学杂志,2020,39(10):1767-1769.[4]蒋秀花,方燕平,黎赛英.院外延续护理对康复期精神分裂症患者服药依从性和生活质量的影响[J].福建医药杂志,2017,39(2):160-162.[5]王翠平.家庭护理对精神分裂症病人康复的临床影响[J].全科护理,2018,16(36):4564-4566.[6]郝伟,于欣.精神病学(第7版)[M].北京:人民卫生出版社,2013:87-89.[7]刘鹏,朱晓丹,闫莉枞,等.微信健康教育对精神分裂症患者服药依从性及生活质量的影响[J].中国健康教育,2021,37(5):466-468.[8]何美.开放性家属同程康复训练护理在精神分裂症患者中的应用[J].检验医学与临床,2017,14(20):3118-3119,3134.[9]李志红.家庭护理干预对精神分裂症患者康复效果的影响[J].护理实践与研究,2018,15(24):150-152.[10]毋炳奎,杨敏.生活质量和社会功能量表评分在强迫症和伴强迫症状的精神分裂症患者临床鉴别诊断[J].中国健康心理学杂志,2015(8):1136-1139,1140.[11]李娜.家庭护理干预对精神分裂症患者预后的影响[J].齐鲁护理杂志,2018,24(14):55-57.[12]牛亚琦,杨辉.家庭护理对精神分裂症病人社会功能的影响[J].护理研究,2018,32(8):1305-1307.[13]汤世明,王锋,杨树旺,等.精神分裂症患者家庭照护者生活质量的影响因素分析[J].医学与社会,2020,33(1):107-111.[14]徐朝英,胡筱峰,张家美,等.家属参与护理对精神分裂症病人社会功能的影响[J].护理研究,2016,30(18):2238-2239.[15]Mokwena KE,Ngoveni A.Challenges of Providing Home Care for a Family Member with Serious Chronic Mental Illness: A Qualitative Enquiry[J].International Journal of Environmental Research and Public Health, 2020,17(22):8440.[16]屠一敏,李霞,曹新妹,等.家属同步教育对精神分裂症患者治疗依从性的影响[J].上海护理,2018,18(4):19-23.[17]王凌玲,邱亚萍,郦兆栋,等.家属参与式护理对精神分裂症患者康复影响的研究[J].重庆医学,2020,49(2):215-218.[18]张微.以家庭为中心的延伸护理方案对精神分裂症患者预后及照护者躯体症状的影响[J].中国临床护理,2016,8(1):43-46.[19]邓风燕,池宝珍,陈蕊.家庭干预模式对以阴性症状为主的精神分裂症患者疗效的影响[J].中国实用护理杂志,2013,29(23):41-43.[20]Aass LK,Skundberg-Kletthagen H,Schr?der A,et al.Young Adults and Their Families Living With Mental Illness: Evaluation of the Usefulness of Family-Centered Support Conversations in Community Mental Health care Settings[J].J Fam Nurs,2020,26(4):302-314.[21]朱文波.家属参与式护理对精神分裂症病人自我管理能力及生活质量的影响[J].全科护理,2019,17(14):1689-1691.

相似文献/References:

[1]邹超杰,程宇琪.肠道微生物在精神分裂症中的研究进展[J].医学信息,2018,31(02):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
　ZOU Chao-jie,CHENG Yu-qi.Progress in the Study of Intestinal Microorganism in Schizophrenia[J].Medical Information,2018,31(02):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
[2]张 健,江 芮.生活技能训练对精神分裂症缓解期患者日常生活能力的影响[J].医学信息,2018,31(03):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
　ZHANG Jian,JIANG Rui.Effect of Life Skills Training on Daily Living Ability of Patients with Schizophrenia in Remission Staged[J].Medical Information,2018,31(02):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
[3]沈雪梅.齐拉西酮与奥氮平治疗首发精神分裂症 疗效及糖脂代谢的影响观察[J].医学信息,2018,31(06):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
　SHEN XUE-mei.The Effect of Ziprasidone and Olanzapine in the Treatment of First Episode Schizophrenia and the Effect of Glycolipid Metabolism[J].Medical Information,2018,31(02):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
[4]陈功琦,梁道博.利培酮联合舍曲林治疗精神分裂症阴性症状 疗效和安全性的Meta分析[J].医学信息,2018,31(10):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
　CHEN Gong-qi,LIANG Dao-bo.Meta Analysis of Efficacy and Safety of Risperidone Combined with Sertraline in the Treatment of Schizophrenia with Negative Symptoms[J].Medical Information,2018,31(02):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
[5]孙占娟.精神分裂症患者的认知康复治疗进展[J].医学信息,2018,31(13):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
　SUN Zhan-juan.Progress in Cognitive Rehabilitation Therapy of Schizophrenia Patients[J].Medical Information,2018,31(02):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
[6]吴金丽.阿立哌唑的临床应用[J].医学信息,2018,31(14):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
　WU Jin-li.Clinical Application of Aripiprazole[J].Medical Information,2018,31(02):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
[7]宋典雄.激励理论指导下的护理干预对精神分裂症患者的影响[J].医学信息,2018,31(18):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
　SONG Dian-xiong.The Effect of Nursing Intervention under the Guidance of Motivation Theory on Patients with Schizophrenia[J].Medical Information,2018,31(02):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
[8]凌 梅,刘静芳.精神分裂症患者研究伙伴的相关研究进展[J].医学信息,2018,31(19):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
　LING Mei,LIU Jing-fang.Progress in Research on Research Partners in Patients with Schizophrenia[J].Medical Information,2018,31(02):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
[9]韩佳睿,张 苹,张 媛.迟发性运动障碍与DNA甲基化之间关系的研究进展[J].医学信息,2018,31(20):32.[doi:10.3969/j.issn.1006-1959.2018.20.010]
　HAN Jia-rui,ZHANG Ping,ZHANG Yuan.Advances in Research on the Relationship between Tardive Dyskinesia and DNA Methylation[J].Medical Information,2018,31(02):32.[doi:10.3969/j.issn.1006-1959.2018.20.010]
[10]陈宽玉,孔 骞,黄玉桃.首发缓解期精神分裂症患者日常生活模式的调查[J].医学信息,2019,32(04):182.[doi:10.3969/j.issn.1006-1959.2019.04.061]
　CHEN Kuan-yu,KONG Qian,HUANG Yu-tao.Investigation on the Daily Life Pattern of Patients with Schizophrenia in the First Remission Period[J].Medical Information,2019,32(02):182.[doi:10.3969/j.issn.1006-1959.2019.04.061]

更新日期/Last Update: 1900-01-01